Tiverton Asset Management’s Zimmer Biomet ZBH Stock Holding History

Tiverton Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$541K	Sell	4,061 -1,539	-27%	-$199K	0.02%	385
2019 Q2	$640K	Buy	5,600 +234	+4%	+$27.4K	0.02%	333
2019 Q1	$665K	Buy	5,366 +3,446	+179%	+$392K	0.03%	290
2018 Q4	$193K	Hold	1,920	–	–	0.01%	313
2018 Q3	$245K	Sell	1,920 -288	-13%	-$34.2K	0.01%	307
2018 Q2	$239K	Sell	2,208 -138	-6%	-$15K	0.01%	299
2018 Q1	$248K	Buy	2,346 +93	+4%	+$10.8K	0.02%	288
2017 Q4	$264K	Buy	+2,253	New	+$255K	0.02%	322

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Tiverton Asset Management's ZBH Position: Q3 2019 in Review

Tiverton Asset Management reduced its Zimmer Biomet (ZBH) stake by 27% in Q3 2019, selling an estimated $199K and leaving 4,061 shares worth $541K. The position accounts for 0.02% of the portfolio, ranked #385.

Tiverton Asset Management first reported a position in ZBH in Q4 2017 and has held it in 8 quarters since. The position peaked at $665K in Q1 2019. 896 funds tracked by Wall St. Rank hold ZBH as of Q3 2019.

Tiverton Asset Management held 4,061 shares of Zimmer Biomet worth $541K as of Q3 2019.
Tiverton Asset Management sold 1,539 Zimmer Biomet shares in Q3 2019, an estimated $199K.
Zimmer Biomet made up 0.02% of Tiverton Asset Management's portfolio in Q3 2019, its #385 holding.
Tiverton Asset Management first reported a position in Zimmer Biomet in Q4 2017 and has held it in 8 quarters since.
Tiverton Asset Management's Zimmer Biomet position peaked at $665K in Q1 2019.
896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.